New Strategy Shows Potential to Block Nerve Loss in Neurodegenerative Diseases

Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner in the death of axons, the wiring of the nervous system. Read more…